The phenomenon is a familiar one: the sudden and profound loss of appetite that accompanies a severe gastrointestinal illness. While…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Glioblastoma Beyond the Brain: Study Reveals How Lethal Tumors Reshape the Skull and Hijack the Immune System to Fuel Aggression
The traditional understanding of glioblastoma—a devastating and primary form of brain cancer—has long characterized the disease as a localized phenomenon,…
Read More
Glioblastoma Immune Cells Hijack Fructose Metabolism to Suppress Anti-Tumor Responses, Unveiling a Novel Therapeutic Pathway.
In a significant breakthrough that could reshape the therapeutic landscape for one of the most aggressive and intractable brain cancers,…
Read More
A little birdie told us that immune genes influence the gut microbiome and vice versa
A groundbreaking study conducted by scientists at the University of East Anglia (UEA) in the UK has revealed a fundamental…
Read More
Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape
The findings from a landmark study conducted by researchers at the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert…
Read More
